New insider Izquierdo Sabido Agustin claimed ownership of 14,648 units of Class A Ordinary Shares (SEC Form 3)
$LYB
Major Chemicals
Industrials
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/01/2025 |
3. Issuer Name and Ticker or Trading Symbol
LyondellBasell Industries N.V. [ LYB ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Class A Ordinary Shares | 14,648(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Options (Right to buy)(2) | (2) | 05/23/2033 | Class A Ordinary Shares | 1,607 | $94.65 | D | |
| Explanation of Responses: |
| 1. Represents 14,648 restricted stock units ("RSUs") granted pursuant to the issuer's long-term incentive plan: 4,112 granted on November 15, 2022 that vest on November 15, 2025; 424 granted on February 23, 2023 that vest on February 23, 2026; 629 granted on November 15, 2023 that vest on November 15, 2025; 242 granted on February 22, 2024 that vest on February 22, 2026; 242 granted on February 22, 2024 that vest on February 22, 2027; 182 granted on April 15, 2024 that vest on April 15, 2025; 182 granted on April 15, 2024 that vest on April 15, 2026; 182 granted on April 15, 2024 that vest on April 15, 2027; 2,819 granted on February 27, 2025 that vest on February 27, 2026; 2,817 granted on February 27, 2025 that vest on February 27, 2027 and 2,817 granted on February 27, 2025 that vest on February 27, 2028. |
| 2. Granted pursuant to the issuer's long-term incentive plan. Award vests as follows: 537 vested on February 23, 2024, 535 vested on February 23, 2025 and 535 vest on February 23, 2026. |
| Remarks: |
| /s/ Lara A. Mason, Attorney-in-Fact | 03/07/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||